Literature DB >> 21279695

The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.

Lubin Qiu1, Dongsheng He, Xiang Fan, Zhi Li, Chuangxin Liao, Yonghong Zhu, Haijun Wang.   

Abstract

The IL-17 plays a crucial role in the invasion of tumors. However, the effects of IL-17 on the invasion of human pituitary adenomas are still unknown. The current study is designed to investigate the possible involvement of IL-17 in the invasion of adenomas. By collecting invasive and non-invasive pituitary adenomas, the mRNA and protein levels of IL-17, IL-17R and MMP-9 are investigated. The results obtained from IHC showed that the strong positive rate and the total positive rate of IL-17, IL-17R and MMP-9 expression cells in the non-invasive group were 17.1 and 51.43%, 14.3 and 54.3%, 17.1 and 57.1%, respectively. In contrast, the strong positive rate and the total positive rate of the invasive group were significantly higher than that of the non-invasive group, which were 37.5 and 82.5%, 52.5 and 87.5%, 67.5 and 92.5%, respectively. Meanwhile, the serum IL-17 level in the invasive pituitary adenomas patients was significantly higher than in the non-invasive groups (P < 0.05). Furthermore, the mRNA levels of IL-17, IL-17R and MMP-9 were also higher in the invasive group than in the non-invasive group with statistical differences (P < 0.05), and where the expression levels of IL-17 and IL-17R had positive correlation with that of MMP-9 in the invasive group. These results suggested that IL-17 may promote the invasion of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279695     DOI: 10.1007/s11102-011-0292-5

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  46 in total

1.  The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells.

Authors:  Sutatip Pongcharoen; Pannika Niumsup; Donruedee Sanguansermsri; Kwansuda Supalap; Puntharee Butkhamchot
Journal:  Am J Reprod Immunol       Date:  2006-04       Impact factor: 3.886

Review 2.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 3.  Interleukin-17 and its receptor.

Authors:  M K Spriggs
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

4.  Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

Authors:  E Tartour; F Fossiez; I Joyeux; A Galinha; A Gey; E Claret; X Sastre-Garau; J Couturier; V Mosseri; V Vives; J Banchereau; W H Fridman; J Wijdenes; S Lebecque; C Sautès-Fridman
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

5.  Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis.

Authors:  D V Jovanovic; J Martel-Pelletier; J A Di Battista; F Mineau; F C Jolicoeur; M Benderdour; J P Pelletier
Journal:  Arthritis Rheum       Date:  2000-05

6.  Role of matrix metalloproteinase 9 in pituitary tumor behavior.

Authors:  H E Turner; Z Nagy; M M Esiri; A L Harris; J A Wass
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

7.  Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts.

Authors:  M C Honorati; S Neri; L Cattini; A Facchini
Journal:  Osteoarthritis Cartilage       Date:  2005-11-28       Impact factor: 6.576

8.  Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.

Authors:  Laurence Blavier; Alisa Lazaryev; Frederick Dorey; Gregory M Shackleford; Yves A DeClerck
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

9.  Giant pituitary tumors: a study based on surgical treatment of 118 cases.

Authors:  Atul Goel; Trimurti Nadkarni; Dattatraya Muzumdar; Ketan Desai; Umesh Phalke; Praveen Sharma
Journal:  Surg Neurol       Date:  2004-05

10.  The prevalence of Th17 cells in patients with gastric cancer.

Authors:  Bin Zhang; Guanghua Rong; Huafeng Wei; Meng Zhang; Jianwei Bi; Liye Ma; Xuchao Xue; Guo Wei; Xiaokang Liu; Guoen Fang
Journal:  Biochem Biophys Res Commun       Date:  2008-07-23       Impact factor: 3.575

View more
  13 in total

Review 1.  Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Authors:  W Saeger; S Petersenn; C Schöfl; U J Knappe; M Theodoropoulou; R Buslei; J Honegger
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

2.  Prognostic significance of interleukin-17 in solid tumors: a meta-analysis.

Authors:  Yunhui Zeng; Qiongwen Zhang; Hong Wang; Minxun Lu; Hongyu Kong; Yingyi Zhang; Huashan Shi
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Factors influencing improvement of visual field after trans-sphenoidal resection of pituitary macroadenomas: a retrospective cohort study.

Authors:  Fen-Fen Yu; Li-Li Chen; Yi-Hua Su; Li-Hun Huo; Xian-Xuan Lin; Rui-Duan Liao
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

Review 4.  Aggressive pituitary tumours and pituitary carcinomas.

Authors:  Gérald Raverot; Mirela Diana Ilie; Hélène Lasolle; Vincent Amodru; Jacqueline Trouillas; Frédéric Castinetti; Thierry Brue
Journal:  Nat Rev Endocrinol       Date:  2021-09-07       Impact factor: 43.330

5.  Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma.

Authors:  Boon Yean Chai; Wai Kien Yip; Noraini Dusa; Norhafizah Mohtarrudin; Heng Fong Seow
Journal:  Pathol Oncol Res       Date:  2020-05-27       Impact factor: 3.201

6.  The Pituitary Tumors and Their Tumor-Specific Microenvironment.

Authors:  M M Kameda-Smith; J -Q Lu
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas.

Authors:  S Cannavo; F Ferrau; O R Cotta; S Saitta; V Barresi; M T Cristani; A Saija; R M Ruggeri; F Trimarchi; S Gangemi
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

8.  Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenoma.

Authors:  Jiayin An; Yin Zhang; Jiaojiang He; Zhenle Zang; Zheng Zhou; Xiangdong Pei; Xin Zheng; Weihua Zhang; Hui Yang; Song Li
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

Review 9.  Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu.

Authors:  Michela Colombo; Leonardo Mirandola; Maurizio Chiriva-Internati; Andrea Basile; Massimo Locati; Elena Lesma; Raffaella Chiaramonte; Natalia Platonova
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

Review 10.  Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.

Authors:  Hong-Yan Liu; Wei-Jun Gu; Cheng-Zhi Wang; Xiao-Jian Ji; Yi-Ming Mu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.